Reliv' International Inc (RELV, Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017. Reliv' International Inc is a developer, manufacturer and marketer of a proprietary line of nutritional supplements addressing basic nutrition, specific wellness needs, weight management and sports nutrition. Reliv' International Inc has a market cap of $8.780 million; its shares were traded at around $4.76 with and P/S ratio of 0.20.
For the last quarter Reliv' International Inc reported a revenue of $9.94 million, compared with the revenue of $10.64 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $41.8 million, a decrease of 8.2% from the previous year. For the last five years Reliv' International Inc had an average revenue decline of 10.3% a year.
The reported loss per diluted share was 38 cents for the year, compared with the loss per share of $0.42 in the previous year. The Reliv' International Inc had an operating margin of -0.44%, compared with the operating margin of -1.78% a year before. The 10-year historical median operating margin of Reliv' International Inc is 2.43%. The profitability rank of the company is 4 (out of 10).
At the end of the fiscal year, Reliv' International Inc has the cash and cash equivalents of $3.27 million, compared with $3.61 million in the previous year. The company had no long term debt, compared with $2.52 million in the previous year. Reliv' International Inc has a financial strength rank of 6 (out of 10).
At the current stock price of $4.76, Reliv' International Inc is traded at 31.1% discount to its historical median P/S valuation band of $6.91. The P/S ratio of the stock is 0.20, while the historical median P/S ratio is 0.30. The stock lost 10.53% during the past 12 months.
For the complete 20-year historical financial data of RELV, click here.
